<div style="display: flex; align-items: center;">
  <!-- Left side: Profile picture (circle) -->
  <div style="margin-right: 30px;">
    <img src="SB.jpg" alt="Profile Picture" width="140" style="border-radius: 50%;">
  </div>

  <!-- Middle section: Additional text -->
  <div>
    <p><b>Expert Immunology Data Science<br>IMM Data Science Department<br>Novartis Pharma<br>Basel, Switzerland</b></p>
  </div>

  <!-- Right side: Logos for LinkedIn, Google Scholar, GitHub -->
  <div>
    <ul style="list-style: none; padding: 0;">
      <li style="margin-bottom: 8px;"><a href="mailto:barman.sumanta@gmail.com" style="margin-left: 300px;"><img src="Email-logo.png" alt="Email" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://www.linkedin.com/in/dr-sumanta-barman-327954143/" style="margin-left: 300px;"><img src="linkedIn_logo.png" alt="LinkedIn" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://scholar.google.com/citations?user=GUAu_j0AAAAJ&hl=en" style="margin-left: 300px;"><img src="google_scholar_logo.png" alt="Google Scholar" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://github.com/sumanta-barman" style="margin-left: 300px;"><img src="github-logo.png" alt="GitHub" width="30"></a></li>
    </ul>
  </div>
</div>

---
<html>
<head>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>My Website</title>
  <style>

    /* Offset the scroll position by a fixed amount */
:target::before {
  content: "";
  display: block;
  height: 130px; /* Adjust this value based on the height of your fixed navigation bar */
  margin-top: -130px; /* Should be the same as the height */
}

  #sticky-menu {
  position: sticky;
  top: 0;
  background-color: #fff;
  padding: 10px;
  z-index: 1;
}
  #sticky-menu nav {
display: flex;
  justify-content: center;
  align-items: center;
  flex-wrap: wrap; /* Add this line */
}
  #sticky-menu nav a {
margin-right: 10px;
  text-decoration: none;
  color: 3300CC; /* Change the color to blue 3300CC; */
  font-weight: bold; /* Make the text bold */
  white-space: nowrap;
}
    #sticky-menu nav a:last-child {
  margin-right: 0;
}

  #sticky-menu nav a.home::before {
      content: "";
      display: inline-block;
      width: 20px; /* Adjust the width as per your logo size */
      height: 20px; /* Adjust the height as per your logo size */
      background-image: url("home_icon.png"); /* Replace with your logo file name */
      background-size: contain;
      background-repeat: no-repeat;
      margin-right: 5px; /* Add some spacing between the logo and the text */
      vertical-align: middle;
    }


#sticky-menu nav a:not(.home)::before {
      content: "► ";
      color: #339933; /* GitHub Cayman theme green color */
    }

  </style>
</head>
<body>
<div id="sticky-menu">
<div style="text-align: justify;">
  
  <nav style="display: flex; justify-content: space-between;">
    <a href="#top" class="home">Home</a>
    <a href="#news">News</a>
    <a href="#about-me">About Me</a>
    <a href="#expertise">Expertise</a>
    <a href="#relevant-methods">Relevant Methods</a>
    <a href="#research-highlights">Research Highlights</a>
    <a href="#tools-and-technologies">Tools and Technologies</a>
    <a href="#professional-experiences">Professional Experiences</a>
    <a href="#education">Education</a>
    <a href="#research-articles">Research Articles</a>
    <a href="#complete-list-of-publications">Complete List of Publications</a>
    <a href="#certifications">Certifications</a>
    <a href="#awards-and-grants">Awards and Grants</a>
    <a href="#interests">Interests</a>
    <div style="display: flex;">
      <a href="#blog">Blog</a>
      <a href="#contact-me">Contact Me</a>
    </div>
  </nav>
</div>  
</div> 
 
</body>
</html>


---

## <b>News</b>

<style>
.collapse {
  cursor: pointer;
  color: #0077b3;
}

.collapse-content {
  display: none;
}
</style>

<div class="collapse">
  <span>&#9658;</span> <b> Novermber 4, 2024: I have started a position as Expert Immunology Data Science at Novartis, Switzerland</b>
</div>

<div class="collapse">
  <span>&#9658;</span> <b>Conference presentation</b> <span style="color: #0077b3;">(click to read more)</span>
</div>

<div class="collapse-content">
  <div style="text-align: justify;">
    <ul>
        <b>June 30, 2024:</b> I have given an oral presentation about our recent work at <a href="https://ectrims.eu/ectrims2024/" target="_blank">The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis</a>, which will take place on 18-20 September 2024 in Copenhagen, Denmark. The presentation is titled <b>"Secondary Autoimmunity after Alemtuzumab treatment in MS: Longitudinal immune repeertoire study suggests pre-existing predisposition ".</b>
      </ul>
  </div>


  <div style="text-align: justify;">
    <ul>
        <b>May 10, 2024:</b> I am going to present our recent work at <a href="https://sng-ssn2024.congress-imk.ch" target="_blank">Swiss Neurological Society (SNS) annual meeting 2024 </a>, which will take place on June 6th, 2024 in Basel, Switzerland. The presentation is titled <b>"Dynamic Reshaping of Lymphocyte Repertoires in Multiple Sclerosis Patients Treated with Alemtuzumab: Insights into Secondary Autoimmunity".</b>
      </ul>
  </div>
</div>

<div class="collapse">
  <span>&#9658;</span> <b>New publication </b> (click to read more)
</div>

<div class="collapse-content">
  <div style="text-align: justify;">
      <ul>
        <b>July 02, 2024:</b> Our recent article has been published in <a href="https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00266-4/fulltext" target="_blank"><b>eBioMedicine</b>:</a> Christopher Nelke, Christina B. Schroeter, <strong>Sumanta Barman</strong>, Frauke Stascheit, Lars Masanneck, Lukas Theissen, Niklas Huntemann, Sara Walli, Derya Cengiz, Vera Dobelmann, Anna Vogelsang, Marc Pawlitzki, Saskia Räuber, Felix F. Konen, Thomas Skripuletz, Hans-Peter Hartung, Simone König, Andreas Roos, Andreas Meisel, Sven G. Meuth, and Tobias Ruck. The article is titled <b>"Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering"</b> and for this study, I had the privilege of conducting the B cell receptor (BCR) repertoire analysis of myasthenia gravis patients using Python and R-based tools, a bash scripts-based pipeline, and custom scripts.
      </ul>
  </div>
  

  <div style="text-align: justify;">
      <ul>
        <b>June 10, 2024:</b> Our recent article has been published in <a href="https://www.nature.com/articles/s41467-024-49209-w" target="_blank"><b>Nature Communications</b>:</a> Nicole Caduff, Lisa Rieble, Michelle Böni, Donal McHugh, Romin Roshan, Wendell Miley, Nazzarena Labo, <strong>Sumanta Barman</strong>, Matthew Trivett, Douwe M. T. Bosma, Julia Rühl, Norbert Goebels, Denise Whitby, Christian Münz. The article is titled <b>"T cell specificity and protective functions elicited by KSHV infection of B cells in vivo"</b> and I was involved in the TCR repertoire data analysis in EBV and EBV+KSHV infected humanized mice.
      </ul>
  </div>
</div>



---


## <b>About Me</b>

  <div style="display: flex; justify-content: center; align-items: center;">
    <img src="computational_immunology.jpeg" alt="aboutme image" style="max-width: 30%; height: auto; margin-right: 10px;">
  </div>


<div style="text-align: justify;">

I am a neuroimmunology scientist with extensive expertise in central nervous system (CNS) autoimmune diseases. My research focuses on leveraging molecular biology, computational immunology, and cutting-edge '-omics' technologies to extract valuable insights and drive significant progress in the field of neuroimmunology. I possess extensive expertise in analysis of large multi-omics (single cell and multimodal transcriptomics, proteomics, single cell and bulk immunogenomics) data sets, next-generation sequencing (NGS), both in laboratory and computational, and single B cell recombinant antibody technology. <br><br>My mastery of data analysis using Python and R, coupled with machine learning and deep learning-based tools, empowers me to make informed decisions based on data and evidence. A significant aspect of my work involves data-driven investigation of treatment effects from various immunotherapies on patients' immune repertoires, as well as contributing to the development and characterization of recombinant human monoclonal antibodies derived from clonally expanded plasma cells (cePc). I possess good knowledge of statistical approaches, utilizing tools such as R, SPSS and GraphPad Prism, to derive meaningful insights and statistical interpretations in research. Furthermore, I am deeply passionate about the application of artificial intelligence (AI) in healthcare and its potential to revolutionize precision medicine.<br><br>My dedication and perseverance have resulted in numerous scientific publications and presentations, both oral and poster, at national and international conferences. Moreover, I have had the privilege of mentoring multicultural students in all aspects of research, including project conception, methodology, data analysis, presentation, and report writing for bachelor's, master's, and PhD theses.


</div>

---

## <b>Expertise</b>

- Molecular biology and computational immunology
- Multi-omics technologies
- Next generation sequencing (NGS)
- Bulk and single cell RNA-Seq data analysis
- Recombinant human monoclonal antibody technology



---

## <b>Relevant Methods</b>

  <div style="display: flex; justify-content: center; align-items: center;">
    <img src="methods.png" alt="method image" style="max-width: 30%; height: auto; margin-right: 10px;">
  </div>

+ NGS library preparation, data acquisition, quality control, visualization, statistical analysis, and interpretation
+ Bulk RNA-seq, single cell RNA-Seq, CITE-seq, transcriptomics, proteomics, immunogenomics data analysis using R and Python-based tools, custom scripts
and bash scripts-based pipeline
+ Computational downstream analysis of scRNA-seq, immunogenomics data using machine and deep learning-based tools
+ Mammalian cell culture
+ Stable and transient cell line generation
+ Cloning, Transformation, Transfection
+ PCR, Single cell RT-PCR, qPCR
+ Flow cytometry
+ Affinity chromatography

## <b>Research Highlights</b>

<div style="text-align: justify;">
<div class="projects"><b>Single cell sequencing:</b>
         <ul>
                <li>Cerebrospinalcord fluid (CSF) and peripheral blood (PB) single cell-based multi-omics approach (transcriptomics, proteomics, immune repertoire) on cohorts of different autoimmune encephalitis patients (anti-GAD, anti-IgLON5, Seronegative autoimmune encephalitis)</li>
                <li>CITE-seq data analysis of Batf+/+ and Batf-/- mouse bone marrow progenitor cells</li>
          </ul>
</div>

<div class="projects"><b>Bulk sequencing:</b>
        <ul>
  <li>Investigate longitudinal treatment effects of anti-CD20 specific disease-modifying therapy on multiple sclerosis (MS) patients’ immune repertoire</li>
  <li>Investigate longitudinal treatment effects of anti-CD52 disease-modifying therapy on the peripheral immune repertoire of multiple sclerosis patients</li>
  <li>Investigate longitudinal treatment effects of S1P receptor modulator on autimmune lymphocyte repertoire in multiple sclerosis (MS)</li>
  <li>BCR repertoire data analysis in Myasthenia gravis (MG) patients</li>
  <li>TCR repertoire data analysis in EBV and EBV+KSHV infected humanized mice</li>
        </ul>
</div>

<div class="projects"><b>Recombinant monoclonal antibody technology:</b>
        <ul>
  <li>Development and characterization of recombinant human monoclonal antibodies from clonally expanded plasma cells (cePc) of patients with different autoimmune encephalitis (anti-GABA A, anti-IgLON5, anti-NMDAR, anti-CASPR2, anti-LGI1, anti-Hu)</li>        
  <li>Recombinant monoclonal antibodies (anti-GABA A, NMDAR) effect on human brain organoid</li>
  <li>Harpes simples virus 1 (HSV1) encephalitis patient CSF derived recombinant human monoclonal antibody development and characterization</li>

  </ul>
  </div>

</div>


---

## <b>Tools and Technologies</b>

<div style="text-align: justify;">
<head>
  <style>
    pre {
      white-space: pre-wrap;
      word-wrap: break-word;
    }
  </style>
</head>
<body>
  <div style="display: flex; justify-content: center; align-items: center;">
    <img src="r-python.png" alt="Bioinformatics Image" style="max-width: 15%; height: auto; margin-right: 10px;">
    <img src="Seurat_scvi.png" alt="Another Image" style="max-width: 15%; height: auto;">
  </div>
  <br>
  <strong>Programming and Scripting Languages:</strong> Python and R (advance), HTML (beginner)<br>
  <strong>Integrated Development Environments (IDEs) and Notebooks:</strong> RStudio, Jupyter Notebook, Visual Studio Code<br>
  <strong>Bioinformatics:</strong> Bioconductor, IMGT, IMGT/HighV-QUEST, IgBlast, BLAST, MAFFT, VDJdb etc.<br>
  <strong>Data Analysis and Visualization:</strong>
  <pre><b>Single cell sequencing data analysis:</b> Cell Ranger, STAR, Seurat, Scanpy, Scirpy, SCVItools, Change-O, SHazaM, Monocle, Harmony, Dandelion, scRepertoire, NAIR, Propeller, Enclone, GLIPH, Immunearch, Immcantation, Dowser, Tcrdist3, Loupe Browser, Loupe V(D)J Browser, DESeq2, limma etc.<br><br><b>Bulk seq analysis:</b> MiXCR, STAR, VDJtools, Immunearch, Immcantation framework<br><br><b>Others:</b> R Markdown, Pandas, NumPy, Ggplot2, Plotly, Matplotlib, UMAP, t-SNE, TCRex, ViClod etc.</pre>
  <strong>Statistical Analysis:</strong> R, SPSS, GraphPad Prism<br>
  <strong>Operating system:</strong> Linux, Mac-OS, Windows<br>
  <strong>Containerization:</strong> Docker<br>
  <strong>Version Control:</strong> Git<br>
  <strong>Others:</strong> High-performance computing, Machine learning and Deep learning (Intermediate)<br>
</body>
</div>



---

## <b>Professional Experiences</b>

<div style="text-align: justify;">
<div class="Professional Experience-section">
        <div class="Professional Experience-title">2024 to date</div>
        <div class="degree"><b>Expert Immunology Data Science</b></div>
        <div class="institution">IMM Data Science Department, Novartis, Switzerland</div>

<br>
        <div class="Professional Experience-title">2021 to 2024</div>
        <div class="degree"><b>Postdoctoral researcher</b></div>
        <div class="institution">Department of Neurology, University Hospital Düsseldorf, Germany</div>

<br>

  <div class="Professional Experience-title">2016 – 2021</div>
  <div class="degree"><b>Doctoral researcher</b></div>
  <div class="institution">Department of Neurology, University Hospital Düsseldorf, Germany</div>
 
  </div>
  </div>


---

## <b>Education</b>

  <div style="text-align: justify;">
  <div class="education-section">
        <div class="education-title">2016 – 2021</div>
        <div class="degree"><b>PhD in Neuroimmunology</b> (Grade: <b>summa cum laude</b>)</div>
        <div class="institution">Heinrich Heine University Düsseldorf, Germany</div>
        <div class="thesis">Thesis: Single B cell antibody technology and high-throughput immune repertoire sequencing as complementary tools to better understand central nervous system (CNS) inflammation and treatment effects</div>
  </div>

<br>

  <div class="education-section">
        <div class="education-title">2012 – 2015</div>
        <div class="degree"><b>Master of Science in Biochemistry</b> (Grade: 1.8)</div>
        <div class="institution">Ruhr University Bochum, Germany</div>
        <div class="thesis">Thesis: Identification of antigenic targets in the humoral immune response of inflammatory CNS diseases</div>
  </div>

<br>

  <div class="education-section">
        <div class="education-title">2006 – 2010</div>
        <div class="degree"><b>Bachelor of Science in Genetic Engineering & Biotechnology</b> (Grade: 1.5 in German grading system)</div>
        <div class="institution">Shahjalal University of Science and Technology, Bangladesh</div>
        <div class="thesis">Thesis: Characterization of oral microbes and their antibiotic sensitivity pattern</div>
  </div>
  </div>
---

## <b>Research Articles</b>


<style>
.collapse {
  cursor: pointer;
}

.collapse-content {
  display: none;
}
</style>

<div class="collapse">
  <span>&#9658;</span> <b>Selected Publications</b> (click to read more)
</div>


<div class="collapse-content">
  <p><em>Computational immunology:</em></p>

  <ol>
    <li>
      <strong><a href="https://academic.oup.com/brain/article/145/5/1711/6590581" target="_blank">Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity</a></strong><br>
      <em>Authors:</em>
      <div style="text-align: justify;">
        Tobias Ruck#, <strong>Sumanta Barman#</strong>, Andreas Schulte-Mecklenbeck#, Steffen Pfeuffer#, Falk Steffen, Christopher Nelke, Christina B Schroeter, Alice Willison, Michael Heming, Thomas Müntefering, Nico Melzer, Julia Krämer, Maren Lindner, Marianne Riepenhausen, Catharina C Gross, Luisa Klotz, Stefan Bittner, Paolo A Muraro, Tilman Schneider-Hohendorf, Nicholas Schwab, Gerd Meyer zu Hörste, Norbert Goebels, Sven G Meuth, Heinz Wiendl. <strong>#equally contributing first authors</strong>
      </div>
      <em>Journal:</em> Brain<br>
      <em>Year:</em> 2022<br>
      <a href="https://academic.oup.com/brain/article/145/5/1711/6590581"><img src="awac064f4.jpeg" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00266-4/fulltext" target="_blank">Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering</a></strong><br>
      <em>Authors:</em>
      <div style="text-align: justify;">
        Christopher Nelke, Christina B. Schroeter, <strong>Sumanta Barman</strong>, Frauke Stascheit, Lars Masanneck, Lukas Theissen, Niklas Huntemann, Sara Walli, Derya Cengiz, Vera Dobelmann, Anna Vogelsang, Marc Pawlitzki, Saskia Räuber, Felix F. Konen, Thomas Skripuletz, Hans-Peter Hartung, Simone König, Andreas Roos, Andreas Meisel, Sven G. Meuth, and Tobias Ruck.
      </div>
      <em>Journal:</em> eBioMedicine<br>
      <em>Year:</em> 2024<br>
      <a href="https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(24)00266-4/fulltext"><img src="MG_ebiomedicine.jpg" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1198860/full" target="_blank">Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls</a></strong><br>
      <em>Authors:</em>
      <div style="text-align: justify;">
        Saskia Räuber, Christopher Nelke, Christina B Schroeter, <strong>Sumanta Barman</strong>, Marc Pawlitzki, Jens Ingwersen, Katja Akgün, Rene Günther, Alejandra P Garza, Michaela Marggraf, Ildiko Rita Dunay, Stefanie Schreiber, Stefan Vielhaber, Tjalf Ziemssen, Nico Melzer, Tobias Ruck, Sven G Meuth, Michael Herty.
      </div>
      <em>Journal:</em> Frontiers in Immunology<br>
      <em>Year:</em> 2023<br>
      <a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1198860/full"><img src="https://www.frontiersin.org/files/Articles/1198860/fimmu-14-1198860-HTML/image_m/fimmu-14-1198860-g004.jpg" alt="Thumbnail" width="300"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://www.nature.com/articles/s41467-024-49209-w" target="_blank">T cell specificity and protective functions elicited by KSHV infection of B cells in vivo</a></strong><br>
      <em>Authors:</em>
      <div style="text-align: justify;">
        Nicole Caduff, Lisa Rieble, Michelle Böni, Donal McHugh, Romin Roshan, Wendell Miley, Nazzarena Labo, <strong>Sumanta Barman</strong>, Matthew Trivett, Douwe M. T. Bosma, Julia Rühl, Norbert Goebels, Denise Whitby, Christian Münz.
      </div>
      <em>Journal:</em> Nature Communications<br>
      <em>Year:</em> 2024<br>
      <a href="https://www.nature.com/articles/s41467-024-49209-w"><img src="EBV_KHSV.webp" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong>Dynamic reshaping of lymphocyte repertoires in multiple sclerosis patients treated with Alemtuzumab: Insights into secondary autoimmunity</strong><br>
      <em>Authors:</em> <strong>Sumanta Barman</strong> et al.<br>
      <em>Ready to submit</em>
    </li>
    <br>
    <li>
      <strong>Comprehensive compartment-specific single-cell multi-omics profiling in GAD-autoimmunity</strong><br>
      <em>Authors:</em> <strong>Sumanta Barman</strong>, Saskia Räuber et al.<br>
      <em>On preparation</em>
    </li>
  </ol>

  <p><em>Neuroimmunology:</em></p>

  <ol start="7">
    <li>
      <strong><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.444" target="_blank">NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody</a></strong><br>
      <em>Authors:</em>
      <div style="text-align: justify;">
        Manish Malviya#, <strong>Sumanta Barman#</strong>, Kristin S Golombeck#, Jesús Planagumà#, Francesco Mannara#, Nathalie Strutz‐Seebohm, Claudia Wrzos, Fatih Demir, Christine Baksmeier, Julia Steckel, Kim Kristin Falk, Catharina C Gross, Stjepana Kovac, Kathrin Bönte, Andreas Johnen, Klaus‐Peter Wandinger, Elena Martín‐García, Albert J Becker, Christian E Elger, Nikolaj Klöcker, Heinz Wiendl, Sven G Meuth, Hans‐Peter Hartung, Guiscard Seebohm, Frank Leypoldt, Rafael Maldonado, Christine Stadelmann, Josep Dalmau, Nico Melzer, Norbert Goebels. <strong>#equally contributing first authors</strong>
      </div>
      <em>Journal:</em> Annals of Clinical and Translational Neurology<br>
      <em>Year:</em> 2017<br>
      <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.444"><img src="https://onlinelibrary.wiley.com/cms/asset/20fe6556-ba39-4887-9dbb-0d067072d452/acn3444-fig-0004-m.jpg" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://www.mdpi.com/1422-0067/24/1/248" target="_blank">Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity</a></strong><br>
      <em>Authors:</em> Mercedeh Farhat Sabet, <strong>Sumanta Barman</strong>, Mathias Beller, Sven G Meuth, Nico Melzer, Orhan Aktas, Norbert Goebels, Tim Prozorovski.<br>
      <em>Journal:</em> International Journal of Molecular Sciences<br>
      <em>Year:</em> 2023<br>
      <a href="https://www.mdpi.com/1422-0067/24/1/248"><img src="https://www.mdpi.com/ijms/ijms-24-00248/article_deploy/html/images/ijms-24-00248-g001.png" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00178/full" target="_blank">An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis</a></strong><br>
      <em>Authors:</em> Elsie Amedonu, Christoph Brenker, <strong>Sumanta Barman</strong>, Julian A Schreiber, Sebastian Becker, Stefan Peischard, Nathalie Strutz-Seebohm, Christine Strippel, Andre Dik, Hans-Peter Hartung, Thomas Budde, Heinz Wiendl, Timo Strünker, Bernhard Wünsch, Norbert Goebels, Sven G Meuth, Guiscard Seebohm, Nico Melzer<br>
      <em>Journal:</em> Frontiers in Neurology<br>
      <em>Year:</em> 2019<br>
      <a href="https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00178/full"><img src="https://www.frontiersin.org/files/Articles/425928/fneur-10-00178-HTML/image_m/fneur-10-00178-g003.jpg" alt="Thumbnail" width="300"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.326" target="_blank">Dose‐dependent inhibition of demyelination and microglia activation by IVIG</a></strong><br>
      <em>Authors:</em> Meike Winter, Christine Baksmeier, Julia Steckel, <strong>Sumanta Barman</strong>, Manish Malviya, Melanie Harrer‐Kuster, Hans‐Peter Hartung, Norbert Goebels<br>
      <em>Journal:</em> Annals of Clinical and Translational Neurology<br>
      <em>Year:</em> 2016<br>
      <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.326"><img src="https://onlinelibrary.wiley.com/cms/asset/9b8bfd67-5778-4e1e-b7d5-aac0a7ec3b06/acn3326-fig-0002-m.jpg" alt="Thumbnail" width="200"></a>
    </li>
    <br>
    <li>
      <strong><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25699" target="_blank">N‐methyl‐D‐aspartate receptor antibodies in autoimmune encephalopathy alter oligodendrocyte function</a></strong><br>
      <em>Authors:</em> Carlos Matute, Ana Palma, María Paz Serrano‐Regal, Estibaliz Maudes, <strong>Sumanta Barman</strong>, María Victoria Sánchez‐Gómez, María Domercq, Norbert Goebels, Josep Dalmau.<br>
      <em>Journal:</em> Annals of Neurology<br>
      <em>Year:</em> 2020<br>
      <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25699"><img src="ana25699-fig-0001-m.png" alt="Thumbnail" width="200"></a>
    </li>
  </ol>

  <p><b>Selected conference publications:</b></p>

  <ul>
    <li>Swiss Neurological Society (SNS) annual meeting 2024, Basel, Switzerland, June 6-7, 2024</li>
    <li>Postdoc Workshop - Drug Hunting @ Bayer, Heiligenhaus, Germany, September 21-24, 2022</li>
    <li>American Academy of Neurology Annual Meeting, Seattle, USA, April 2-7, 2022</li>
    <li>ECTRIMS, Stockholm, Sweden, September 11-13, 2019</li>
    <li>Novartis Research Day 2019, Berlin, Germany, January 24-25, 2019</li>
    <li>14th International Congress of Neuroimmunology, Brisbane, Australia, August 27-31, 2018</li>
  </ul>
</div>

<script>
var collapseElements = document.getElementsByClassName("collapse");
for (var i = 0; i < collapseElements.length; i++) {
  collapseElements[i].addEventListener("click", function() {
    this.classList.toggle("active");
    var content = this.nextElementSibling;
    if (content.style.display === "block") {
      content.style.display = "none";
      this.firstElementChild.innerHTML = "&#9658;";
    } else {
      content.style.display = "block";
      this.firstElementChild.innerHTML = "&#9660;";
    }
  });
}
</script>





---

## <b>Complete List of Publications</b>

- You can also find a complete list of my publications [here](https://scholar.google.com/citations?user=GUAu_j0AAAAJ&hl=en).

---

## <b>Certifications</b>


<div style="text-align: justify;">
<div class="Certifications-section">
        <div class="course"><b>Neuroimaging and Precision Medicine,</b> Düsseldorf, Germany</div>
        
<br>
        <div class="course"><b>Mathematics for Informatics 1 and Deep learning,</b> Düsseldorf, Germany</div>
        
<br>        
        <div class="course"><b>Artificial Intelligence (AI) for all (KI für alle),</b> Düsseldorf, Germany</div>

<br> 
        <div class="course"><b>TechLabs Digital Shaper Program (AI, Data science with Python),</b> Düsseldorf, Germany</div>
        
<br> 
        <div class="course"><b>Statistics for Scientists in Medicine with R, SPSS,</b> Düsseldorf, Germany</div>
      
<br> 
        <div class="course"><b>Global School of Neuroimmunology Course,</b> Brisbane, Australia</div>

  <br> 
        <div class="course"><b>Good Scientific Practice,</b> Düsseldorf, Germany</div>

  <br> 
        <div class="course"><b>Instruction in Laboratory Animals Science (FELASA-B),</b> Bayer Health Care, Wuppertal, Germany</div>

  </div>
  </div>

---

## <b>Awards and Grants</b>

+ Heine Research Academies (HeRA) travel grant for participating in the 2022 American Academy of Neurology annual meeting, Seattle, USA
+ Best poster prize award, Novartis Research Day MS 2019, Berlin, Germany
+ International Society of Neuroimmunology travel grant for participating in the 14th International Congress of Neuroimmunology, Brisbane, Australia
+ Received prize for academic excellence in Bachelor of Science
+ Received scholarships for academic excellence in grade 5 and grade 8


---


## <b>Interests</b>

  <div style="display: flex; justify-content: center; align-items: center;">
    <img src="interests.jpg" alt="hobbies image" style="max-width: 25%; height: auto; margin-right: 10px;">
  </div>
   <br> 
  

+ Playing musical instruments
+ Photography
+ Hiking
+ Camping
+ Cycling
+ Coding
+ Writing


---
## <b>Blog</b>

<style>
.collapse {
  cursor: pointer;
  display: flex;
  align-items: center;
  font-size: 1.1em;
  margin-bottom: 8px;
}
.collapse .arrow {
  transition: transform 0.2s;
  margin-right: 7px;
}
.collapse.open .arrow {
  transform: rotate(90deg);
}
.collapse-content {
  display: none;
  margin-left: 20px;
}
.collapse-content.open {
  display: block;
}
.blog-justify {
  text-align: justify;
  text-justify: inter-word;
}
</style>

<!-- Anchor for direct linking -->
<a id="blog1"></a>
<div class="collapse" id="blog1-toggle">
  <span class="arrow">&#9658;</span>
  <b>Blog 1 : Fascinating world of human Brain</b> (click to read more)
</div>

<div class="collapse-content" id="blog1-content">
  <div class="blog-justify">
    <h2>What happens to your brain as you age?</h2>
    <p> Reading time: approximately 4 minutes (To read in Bangla, please scroll down)
    </p>
    <img src="https://raw.githubusercontent.com/sumanta-barman/sumanta-barman.github.io/main/1030_neuron_explainer_feat.jpg"
         alt="Brain illustration"
         style="max-width:100%;height:auto;margin-bottom:20px;border-radius:6px;">
    
    <p>
      <strong>Did you know?</strong> The human brain contains over 100 billion neurons, which create trillions of synapses-complex connections that allow us to think, remember, and feel. These neurons communicate at incredible speeds, with signals traveling up to 250 miles per hour. Despite making up only about 2% of our body weight, the brain consumes about 20-25% of our blood and energy, and when awake, can generate enough electricity to power a small light bulb. The cerebrum, responsible for memory, movement, and reasoning, makes up 85% of the brain’s weight and is divided into two hemispheres, each specializing in different functions. Every time you form a new memory or thought, your brain creates a new connection, making it an ever-changing and dynamic “neuron forest.”
    </p>

    <div style="margin-bottom:20px;">
      <!-- YouTube thumbnail, clickable to open video -->
      <a href="https://www.youtube.com/watch?v=cMim0uU1yzA" target="_blank" rel="noopener">
        <img src="https://img.youtube.com/vi/cMim0uU1yzA/hqdefault.jpg" 
             alt="YouTube Video Thumbnail" 
             title="Watch the video"
             style="max-width:300px;width:100%;height:auto;border-radius:6px;box-shadow:0 2px 8px rgba(0,0,0,0.07);">
      </a>
      <div style="margin-top:8px;">
        Source: The Economist<br>
        <a href="https://www.youtube.com/watch?v=cMim0uU1yzA" target="_blank" rel="noopener">
          https://www.youtube.com/watch?v=cMim0uU1yzA 
        </a>
      </div>
    </div>

    <h3>Key points:</h3>
    <p>
      The video traces the development and transformation of the human brain from before birth through old age and even after death, highlighting key stages and scientific insights at each phase.
    </p>
    <h4>In the Womb</h4>
    <ul>
      <li>The brain begins forming about two weeks after conception, starting as a neural plate that folds into a tube, creating the nervous system.</li>
      <li>Rapid neuron production occurs, with a newborn's brain containing around 100 billion neurons-more than an adult's. These excess neurons are later pruned before adulthood.</li>
    </ul>
    <h4>Childhood</h4>
    <ul>
      <li>Initially, babies have few synapses (connections between neurons), but these increase dramatically in early years, reaching about 15,000 per neuron.</li>
      <li>Myelination (insulation of neurons with a fatty substance called myelin) allows faster information transmission and more complex processes.</li>
      <li>The brain undergoes "synaptic pruning," removing unused connections to improve efficiency-a process known as neuroplasticity.</li>
      <li>This stage is critical for learning, and early experiences can have lasting effects on development.</li>
    </ul>
    <h4>Teenage Years</h4>
    <ul>
      <li>The brain stops growing but continues to develop, especially in terms of myelination.</li>
      <li>Different brain regions mature at different rates: areas linked to reward develop faster than those responsible for self-control and rationality.</li>
      <li>The limbic system (emotions) changes significantly, explaining mood swings and risk-taking behaviors in teens.</li>
      <li>The gap between emotional and rational brain development may contribute to increased risk-taking and susceptibility to addiction.</li>
    </ul>
    <h4>Early Adulthood</h4>
    <ul>
      <li>Brain tissue in the prefrontal cortex (decision-making, self-control) increases, improving connections between emotional and motor centers.</li>
      <li>Full brain development is typically reached by the 30s, with white matter peaking around age 40.</li>
    </ul>
    <h4>Middle Age</h4>
    <ul>
      <li>Neuroplasticity continues, allowing the brain to adapt and compensate for aging.</li>
      <li>Older adults often use both brain hemispheres for tasks like short-term memory, rather than just one side.</li>
      <li>The amygdala (emotion processing) responds less to negative stimuli, possibly making older adults more resilient to stress.</li>
      <li>Experience helps activate neural pathways for handling difficult situations.</li>
      <li>Menopause brings hormonal changes that affect brain energy and connectivity, with some regions becoming more efficient despite a decrease in white matter volume.</li>
    </ul>
    <h4>Later Life</h4>
    <ul>
      <li>The cerebral cortex (outer brain layer) thins, especially in areas important for memory and emotions (frontal lobe, hippocampus).</li>
      <li>White matter shrinks, and levels of neurotransmitters like dopamine and serotonin decrease, slowing cognitive processing.</li>
      <li>The rate of brain aging is influenced by genetics, with noticeable slowing typically starting in the 30s and 40s and accelerating in the 60s and 70s.</li>
    </ul>
    <h4>Death</h4>
    <ul>
      <li>Recent studies show that brain activity may persist for several minutes after the heart stops.</li>
      <li>A surge in certain brain waves just before death may explain reports of life "flashing before your eyes" during near-death experiences.</li>
    </ul>
    <h4>Conclusion</h4>
    <ul>
      <li>The brain is a dynamic, ever-changing organ, adapting throughout life via neuroplasticity, influenced by genetics, experience, and environment.</li>
      <li>Even in old age, the brain can find ways to compensate for decline, and its activity can continue briefly after clinical death.</li>
    </ul>

    <!-- Bangla summary starts here -->
    <hr style="margin:40px 0 30px 0;">
    <h3 style="color:#1a237e;">বাংলা অনুবাদ</h3>
    <p>
      আপনি কি জানেন? মানুষের মস্তিষ্কে ১০০ বিলিয়নেরও বেশি নিউরন রয়েছে, যা ট্রিলিয়ন সংখ্যক সিন্যাপ্স বা জটিল সংযোগ তৈরি করে-যার মাধ্যমে আমরা চিন্তা করি, স্মরণ করি ও অনুভব করি। এই নিউরনগুলো অবিশ্বাস্য গতিতে যোগাযোগ করে, যার সংকেত ঘণ্টায় ২৫০ মাইল পর্যন্ত যেতে পারে। শরীরের মোট ওজনের মাত্র ২% হলেও, মস্তিষ্ক আমাদের রক্ত ও শক্তির প্রায় ২০-২৫% ব্যবহার করে এবং জাগ্রত অবস্থায় একটি ছোট বৈদ্যুতিক বাতি জ্বালানোর মতো বিদ্যুৎ উৎপাদন করতে পারে। স্মৃতি, চলন ও যুক্তির জন্য দায়ী সেরিব্রাম মস্তিষ্কের ৮৫% ওজন নিয়ে গঠিত এবং এটি দুইটি হেমিস্ফিয়ারে বিভক্ত, যার প্রত্যেকটি বিভিন্ন কাজে বিশেষায়িত। আপনি যখনই নতুন কোনো স্মৃতি বা চিন্তা গঠন করেন, তখনই আপনার মস্তিষ্কে একটি নতুন সংযোগ তৈরি হয়, ফলে এটি সদা পরিবর্তনশীল ও গতিশীল এক ‘নিউরন বন’ হয়ে ওঠে।
    </p>
    <p>
      ভিডিওটি মানব মস্তিষ্কের গঠন ও পরিবর্তনের গল্প বলে, জন্মের আগের সময় থেকে শুরু করে বার্ধক্য এবং মৃত্যুর পর পর্যন্ত, প্রতিটি ধাপে বৈজ্ঞানিক তথ্য তুলে ধরে।
    </p>
    <h4>গর্ভাবস্থায়</h4>
    <ul>
      <li>গর্ভধারণের দুই সপ্তাহ পর মস্তিষ্ক গঠিত হতে শুরু করে, যা নিউরাল প্লেট থেকে নিউরাল টিউবে পরিণত হয় এবং স্নায়ুতন্ত্র তৈরি হয়।</li>
      <li>দ্রুত নিউরন উৎপন্ন হয়, নবজাতকের মস্তিষ্কে প্রায় ১০০ বিলিয়ন নিউরন থাকে-যা একজন প্রাপ্তবয়স্কের থেকেও বেশি। এই অতিরিক্ত নিউরন পরবর্তীতে ছাঁটাই (pruning) হয়।</li>
    </ul>
    <h4>শৈশব</h4>
    <ul>
      <li>শিশুরা প্রথমে খুব কম সংযোগ (synapse) নিয়ে জন্মায়, কিন্তু দ্রুতই এগুলো বেড়ে যায়-প্রতি নিউরনে প্রায় ১৫,০০০টি সংযোগ।</li>
      <li>মাইলিনেশন (myelination) নামক প্রক্রিয়ায় নিউরনগুলো চর্বিযুক্ত মাইলিনে আবৃত হয়, ফলে তথ্য দ্রুত পৌঁছে যায়।</li>
      <li>"সিন্যাপটিক প্রুনিং" বা অপ্রয়োজনীয় সংযোগ ছাঁটাইয়ের মাধ্যমে মস্তিষ্ক আরও দক্ষ হয়-এটি নিউরোপ্লাস্টিসিটি নামে পরিচিত।</li>
      <li>এই সময়ে শেখার ক্ষমতা সবচেয়ে বেশি এবং প্রাথমিক অভিজ্ঞতা আজীবন প্রভাব ফেলতে পারে।</li>
    </ul>
    <h4>কৈশোর</h4>
    <ul>
      <li>মস্তিষ্কের বৃদ্ধি থেমে গেলেও, মাইলিনেশন ও সংযোগ উন্নত হতে থাকে।</li>
      <li>বিভিন্ন অংশের পরিপক্কতা ভিন্ন সময়ে হয়: পুরস্কার সংশ্লিষ্ট অংশ দ্রুত পরিপক্ক হয়, কিন্তু আত্মনিয়ন্ত্রণ ও যুক্তিবোধের অংশ পরে পরিপক্ক হয়।</li>
      <li>লিম্বিক সিস্টেম (অনুভূতির কেন্দ্র) ব্যাপকভাবে পরিবর্তিত হয়, যার ফলে কিশোরদের মেজাজ ওঠানামা ও ঝুঁকিপূর্ণ আচরণ দেখা যায়।</li>
      <li>আবেগ ও যুক্তিবোধের বিকাশে ব্যবধান থাকায় কিশোররা বেশি ঝুঁকি নিতে পারে এবং আসক্তির ঝুঁকিও বেশি থাকে।</li>
    </ul>
    <h4>প্রাপ্তবয়স্কতা</h4>
    <ul>
      <li>প্রিফ্রন্টাল কর্টেক্সে (সিদ্ধান্ত গ্রহণ, আত্মনিয়ন্ত্রণ) মস্তিষ্কের টিস্যু বাড়ে এবং সংযোগ উন্নত হয়।</li>
      <li>সাধারণত ৩০ বছর বয়সে মস্তিষ্ক পুরোপুরি পরিপক্ক হয়, এবং হোয়াইট ম্যাটার ৪০ বছর বয়সে সর্বাধিক হয়।</li>
    </ul>
    <h4>মধ্যবয়স</h4>
    <ul>
      <li>নিউরোপ্লাস্টিসিটি অব্যাহত থাকে, ফলে মস্তিষ্ক বার্ধক্যের সাথে খাপ খাইয়ে নিতে পারে।</li>
      <li>বয়স্করা স্মৃতির মতো কাজে উভয় মস্তিষ্ক গোলার্ধ ব্যবহার করেন, তরুণরা যেখানে এক পাশে নির্ভর করে।</li>
      <li>অ্যামিগডালা (অনুভূতি প্রক্রিয়াকরণ) নেতিবাচক উদ্দীপনায় কম প্রতিক্রিয়া দেখায়, ফলে বয়স্করা মানসিক চাপ কম অনুভব করেন।</li>
      <li>অভিজ্ঞতা কঠিন পরিস্থিতি সামলাতে নিউরাল পথ সক্রিয় করতে সাহায্য করে।</li>
      <li>মেনোপজে হরমোন পরিবর্তন মস্তিষ্কের শক্তি ও সংযোগে প্রভাব ফেলে, তবে কিছু অংশ আরও দক্ষ হয়।</li>
    </ul>
    <h4>বার্ধক্য</h4>
    <ul>
      <li>সেরিব্রাল কর্টেক্স (বাইরের স্তর) পাতলা হতে থাকে, বিশেষ করে স্মৃতি ও অনুভূতির অংশে।</li>
      <li>হোয়াইট ম্যাটার কমে যায় এবং ডোপামিন, সেরোটোনিনের মতো নিউরোট্রান্সমিটারের মাত্রা কমে যায়, ফলে চিন্তার গতি কমে।</li>
      <li>মস্তিষ্কের বার্ধক্য জেনেটিক্স দ্বারা প্রভাবিত হয়; ৩০-৪০ বছর থেকে ধীরগতিতে শুরু হয়ে ৬০-৭০ বছর থেকে দ্রুত হয়।</li>
    </ul>
    <h4>মৃত্যু</h4>
    <ul>
      <li>সাম্প্রতিক গবেষণায় দেখা গেছে, হৃদস্পন্দন বন্ধ হওয়ার পরও কয়েক মিনিট মস্তিষ্ক সক্রিয় থাকতে পারে।</li>
      <li>মৃত্যুর ঠিক আগে নির্দিষ্ট ব্রেনওয়েভের উত্থান ঘটে, যা "জীবন চোখের সামনে ভেসে ওঠা" অনুভূতির ব্যাখ্যা হতে পারে।</li>
    </ul>
    <h4>উপসংহার</h4>
    <ul>
      <li>মস্তিষ্ক একটি গতিশীল, পরিবর্তনশীল অঙ্গ, যা জীবনভর অভিজ্ঞতা ও পরিবেশের প্রভাবে নিজেকে বদলাতে পারে (নিউরোপ্লাস্টিসিটি)।</li>
      <li>বার্ধক্যেও মস্তিষ্ক ক্ষয়পূরণ করতে পারে এবং মৃত্যুর পরও কিছু সময় সক্রিয় থাকতে পারে।</li>
    </ul>
    <!-- Bangla summary ends here -->
  </div>
</div>

<script>
document.getElementById('blog1-toggle').onclick = function() {
  this.classList.toggle('open');
  document.getElementById('blog1-content').classList.toggle('open');
};

// Auto-expand if URL has #blog1
if (window.location.hash === "#blog1") {
  document.getElementById('blog1-toggle').classList.add('open');
  document.getElementById('blog1-content').classList.add('open');
  // Optionally scroll into view
  document.getElementById('blog1-toggle').scrollIntoView();
}
</script>


---

## <b>Contact Me</b>

<a href="mailto:barman.sumanta@gmail.com"><img src="Email-logo.png" alt="Email" width="30"></a>
<a href="https://www.linkedin.com/in/dr-sumanta-barman-327954143/"><img src="linkedIn_logo.png" alt="LinkedIn" width="30"></a>
<a href="https://scholar.google.com/citations?user=GUAu_j0AAAAJ&hl=en"><img src="google_scholar_logo.png" alt="Google Scholar" width="30"></a>
<a href="https://github.com/sumanta-barman"><img src="github-logo.png" alt="GitHub" width="30"></a>

---

Feel free to reach out if you are interested in collaboration or have any inquiries related to my research!
  


